EFMH
AXSM icon

E Fund Management (HK)’s Axsome Therapeutics AXSM Stock Holding History

E Fund Management (HK)’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3K Buy
128
+39
+44% +$8.46K 0.01% 230
2026
Q1 		$15K Buy
+89
New +$15.4K 0.01% 250

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

E Fund Management (HK)'s AXSM Position: Q2 2026 in Review

E Fund Management (HK) increased its Axsome Therapeutics (AXSM) stake by 44% in Q2 2026, buying an estimated $8.46K and bringing the position to 128 shares worth $31.3K. The position accounts for 0.01% of the portfolio, ranked #230.

E Fund Management (HK) first reported a position in AXSM in Q1 2026 and has held it in 2 quarters since. 53 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • E Fund Management (HK) held 128 shares of Axsome Therapeutics worth $31.3K as of Q2 2026.
  • E Fund Management (HK) bought 39 Axsome Therapeutics shares in Q2 2026, an estimated $8.46K.
  • Axsome Therapeutics made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #230 holding.
  • E Fund Management (HK) first reported a position in Axsome Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 53 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.